2014 annual financial data
ImmunityBio 2014 Operating margin
Direct answer
Operating margin was -969.11%.
Operating income was -6,212,000 USD and net income was -6,213,000 USD.
Operating cash flow was -5,354,000 USD.
Get free ImmunityBio email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 641,000 USD
- Operating income
- -6,212,000 USD
- Net income
- -6,213,000 USD
- Operating cash flow
- -5,354,000 USD